BeFree+Bot for Smoking Cessation

LA
Overseen ByLorien Abroms, ScD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: George Washington University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines how a special chatbot, BeFree+Bot, might assist people in quitting smoking. Participants will receive either regular text messages about quitting or text messages plus support from the chatbot. The aim is to determine if the chatbot eases the quitting process. This trial suits anyone in the U.S. who has smoked a cigarette in the last week, owns a mobile phone, and is open to receiving daily texts about quitting smoking for a month. As an unphased trial, this study provides a unique opportunity to explore innovative support methods for smoking cessation.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that the BeFree+Bot is safe for smoking cessation?

Studies have shown that using a ChatGPT-based chatbot, like BeFreeBot, may help people quit smoking. Research indicates that users of similar chatbots found them easy to use and helpful. No serious side effects have been reported so far. The BeFree+Bot combines text messages with the chatbot to support smoking cessation. As this is a new method, the study aims to ensure its safety and effectiveness for participants. Although it is still early, using a chatbot to aid smoking cessation appears well-received.12345

Why are researchers excited about this trial?

Researchers are excited about BeFree+Bot for smoking cessation because it combines personalized text messages with access to a specialized ChatGPT chatbot. Unlike traditional methods that often rely on nicotine replacement therapies or counseling, this approach leverages advanced AI technology to offer real-time, tailored support. The chatbot can engage users in meaningful conversations, providing instant motivation and strategies to tackle cravings, making it a potentially more engaging and interactive way to quit smoking.

What evidence suggests that BeFree+Bot could be effective for smoking cessation?

Research shows that the BeFree+Bot, which uses a chatbot and text messages, may help people quit smoking. Participants in the intervention arm of this trial will receive text messages about quitting smoking and access to a specialized ChatGPT chatbot. An earlier study found that 72% of participants were satisfied with the chatbot, and 58% found it helpful in their efforts to quit. These results suggest that adding a specialized ChatGPT chatbot to a stop-smoking program could enhance its effectiveness. While the evidence is still growing, early signs are positive, indicating that many users find the support helpful for quitting smoking.16789

Are You a Good Fit for This Trial?

This trial is for individuals in the US who have smoked a cigarette within the last week, own a mobile phone, and are open to receiving daily health-related text messages for a month to help them quit smoking.

Inclusion Criteria

I live in the US.
I have smoked a cigarette in the past week.
I own a mobile phone.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive text messages about quitting smoking, with one group also having access to a specialized ChatGPT chatbot

4 weeks

Follow-up

Participants are monitored for continuous abstinence from smoking

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • BeFree+Bot
Trial Overview The study compares two methods aimed at quitting smoking: BeFree+Bot, which includes ChatGPT chatbot support, versus BeFree alone. The goal is to see if adding ChatGPT improves outcomes in stopping smoking.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

George Washington University

Lead Sponsor

Trials
263
Recruited
476,000+

Citations

ChatGPT-Based Chatbot for Help Quitting Smoking via ...This pilot study examined the feasibility and acceptability of integrating a specialized ChatGPT-based chatbot, BeFreeBot, into a smoking ...
ChatGPT Chatbot for Help Quitting Smoking via Text ...Most participants were highly satisfied with BeFreeBot (13/18, 72%) and agreed that it was helpful for quitting (11/19, 58%). They also reported ...
Effectiveness of an offer of the Smoke Free smartphone ...The primary outcome measure is self-reported 26-week continuous smoking abstinence. Secondary outcome measures include quit attempts in the first 4 weeks post- ...
Effectiveness of the offer of the Smoke Free smartphone ...Representative observational data show low rates of adoption of digital aids for smoking cessation, with fewer than 3% of smokers who have tried ...
Assessing the Adherence of ChatGPT Chatbots to Public ...Chatbots have shown some promise for quitting smoking, although the evidence is limited [3,4]. One scoping review identified a handful of ...
Texting ChatGPT-based bot shows progress in helping ...GW researchers published a study earlier this month that found texting an anti-smoking bot developed using ChatGPT could help patients quit.
BeFree+Bot for Smoking Cessation · Info for ParticipantsThis N/A medical study run by George Washington University needs participants to evaluate whether BeFree+Bot will have tolerable side effects & efficacy for ...
ChatGPT-Based Chatbot for Help Quitting Smoking via ...This pilot study examined the feasibility and acceptability of integrating a specialized ChatGPT-based chatbot, BeFreeBot, into a smoking ...
Text Message Quit Vaping Intervention for Adolescents ...These include likelihood of making a quit attempt, likelihood of reducing e-cigarette use, and changes in confidence and self-efficacy in ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security